Supernus Pharmaceuticals, Inc. (SUPN)
MD
Total Compensation for Fiscal Year Ending in 2022: $10,012,717
Salary | $913,500 |
---|---|
Bonus | $0 |
Value of Stock Awards | $3,616,250 |
Value of Option Awards | $4,767,500 |
Non-Equity Incentive Plan Compensation | $685,125 |
Change in Pension Value and Deferred Compensation Earnings | $0 |
All Other Compensation | $30,342 |
Total | $10,012,717 |
Supernus Pharmaceuticals, Inc. disclosed its CEO pay was
61
times its median employee's pay for the fiscal year ending in 2022.
How Do You Compare?